Dare Bioscience, Inc.
Pharmaceutical Preparations · SAN DIEGO
Moderate confidence (50%)
Updated Oct 17, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Dare Bioscience, Inc. received a delisting notice from its exchange (Sep 28, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Dare Bioscience, Inc. received a delisting notice from its exchange
Sep 28, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 28, 2026, Dar Bioscience, Inc. ( Dar ) received a letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) notifying Dar that, for the last 30 consecutive business days, the closing bid price for Dar s common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Requirement ). The letter has no immediate eff…”
Dare Bioscience, Inc. received a delisting notice from its exchange
Jul 13, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 13, 2026, Dare Biosciences, Inc. (the Company ) was notified by the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) that, because the Company s Form 10-Q for the period ended March 31, 2026 reported stockholders equity of less than $2.5 million and, as of July 13, 2026, the Company did not meet the alternative requirements of $35 million in market value of listed securities or $500,000 in net income from continuing operations, the Company no…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker DARE on Nasdaq.
- SEC CIK
- 0001401914
- Website
- —
- —
- Headquarters
- SAN DIEGO
- Also known as
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Legal entities
- Dare Bioscience, Inc.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 28, 2026, Dar Bioscience, Inc. ( Dar ) received a letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) notifying Dar that, for the last 30 consecutive business days, the closing bid price for Dar s common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Requirement ). The letter has no immediate eff…
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
Dare Bioscience, Inc. — Pharmaceutical Preparations (SIC 2834) — SAN DIEGO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 13, 2026, Dare Biosciences, Inc. (the Company ) was notified by the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) that, because the Company s Form 10-Q for the period ended March 31, 2026 reported stockholders equity of less than $2.5 million and, as of July 13, 2026, the Company did not meet the alternative requirements of $35 million in market value of listed securities or $500,000 in net income from continuing operations, the Company no…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:01 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:22 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.